Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
PPCBPropanc Biopharma, Inc.
| Figure | PPCBPropanc Biopharma, Inc.FY2026 · Jun |
|---|---|
| Revenue | — |
| Revenue, yoy | — |
| Net income | $18.86M |
| Net income, yoy | +68.0% |
| Net margin | — |
| Free cash flow | $5.69M |
| FCF margin | — |
| EPS, diluted | $17.62 |
Add another company.
Annual · USD
No annual figures on file for this.
From SEC EDGARSame fiscal periods, as filed